U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Method for continuously producing citric acid by dual hollow fiber membrane bioreactor

Patent 4910139 Issued on March 20, 1990. Estimated Expiration Date: Icon_subject August 1, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Inventors

Assignee

Application

No. 226718 filed on 08/01/1988

US Classes:

435/144, Tricarboxylic acid (e.g., citric acid, etc.)435/917Aspergillus niger

Examiners

Primary: Lilling, Herbert J.

Attorney, Agent or Firm

Foreign Patent References

  • 2507500 FR 12/21/1982
  • 0907072 SU 02/21/1982

International Classes

C12P 007/48
C12R 001/645

Foreign Application Priority Data

1987-09-09 KR

Abstract

Aspergillus niger B60 was immobilized in a dual hollow fiber bioreactor to produce citric acid continuously. The fungi proliferated well in the interstitial region formed by a parallel arrangement of three microporous polypropylene hollow fibers contained within a silicone tube. Excessive fungal cell growth could be controlled by supplying a nitrogen-deficient medium at the production stage, and also uniform cell distribution in the reactor could be obtained by changing the direction of medium flow. With pure oxygen aeration and nitrogen-deficient medium, volumetric productivity reached 1.62 g/l.h at a residence time of 4.02 h, which corresponded to a 27-fold increase over that of shake-flask fermentation. When the residence time was increased to 20.1 h, citric acid at a concentration of 26 g/l was continuously produced, with a yield of 80-90% and a volumetric productivity of 1.3 g/l.h. This represents a significant improvement in final concentration, yield and the volumetric productivity over the equivalent values of the corresponding batch formentation, which were 18 g/l, 40% and 0.06 g/l.h, respectively.

Other References

  • Derwent Abstract, 82-64080E/31, Eysmond Fr 2496122, (6-82)
  • Biotech, 88-0857, Chung et al., Biotech Bioeng, 1988, 32, 2, 205-12
  • Biotech, 87-08034, Eikmeier Z. Naturforsch C, (1987), 42, 4, 408-13
  • Biotech, 87-01837, Chang et al., ACS Symp., (1986), 314
  • Biotech, 85-02469, Mahala et al., World Biotech Rep., 1984, 2, A129-140
  • Derwent Abs., 79-45384 B/24, Metkin et al., SU-619511, (7-1978)
  • Derwent Abs., 78-71922A/40, Metkin et al., SU 579303, (11-1978)
  • Derwent Abs., 81-00326D/01, Blain et al., GB 1581832, (12-1980
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?